Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both?

被引：3
|
作者：
Einhorn, Lawrence H. [1 ,2 ]
Abonour, Rafat [1 ]
Kesler, Kenneth A.
机构：
[1] Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[2] Indiana Univ Sch Med, Lance Armstrong Fdn Chair Oncol, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 35期
关键词：
EXPERIENCE; POSTCHEMOTHERAPY;
D O I：
10.1200/JCO.2010.30.4626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E739 / E739
页数：1
相关论文
共 50 条
  • [41] Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT)
    Taza, Fadi
    Abonour, Rafat
    Zaid, Mohammad Abu
    Althouse, Sandra K.
    Anouti, Bilal
    Akel, Reem
    Hanna, Nasser H.
    Adra, Nabil
    Einhorn, Lawrence H.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 213 - 220
  • [42] Sequential high dose chemotherapy with paclitaxel and etoposide, carboplatin, melphalan and autologous stem cell support in patients with germ cell tumors; a phase II study
    Koumakis, G.
    Tryfonopoulos, D.
    Vassilomanolakis, M.
    Barbounis, V.
    Res, E.
    Demiri, S.
    Tsoukalas, N.
    Droufakou, S.
    Filis, I.
    Efremidis, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 305 - 305
  • [43] HIGH-DOSE CARBOPLATIN VP-16 PLUS IFOSFAMIDE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN THE TREATMENT OF REFRACTORY GERM-CELL TUMORS
    BROUN, ER
    NICHOLS, CR
    TRICOT, G
    LOEHRER, PJ
    WILLIAMS, SD
    EINHORN, LH
    BONE MARROW TRANSPLANTATION, 1991, 7 (01) : 53 - 56
  • [44] Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation
    Erturk, Ismail
    Karadurmus, Nuri
    Kiziloz, Halil
    Acar, Ramazan
    Yildiz, Birol
    Aykan, Musa Baris
    Esen, Ramazan
    Buyukturan, Galip
    Urun, Yuksel
    Erdem, Gokhan
    Arpaci, Fikret
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1657 - 1664
  • [45] Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome
    J Beyer
    O Rick
    S Weinknecht
    D Kingreen
    K Lenz
    W Siegert
    Bone Marrow Transplantation, 1997, 20 : 813 - 819
  • [46] Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: Incidence and implications for hematologic recovery and clinical outcome
    Beyer, J
    Rick, O
    Weinknecht, S
    Kingreen, D
    Lenz, K
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1997, 20 (10) : 813 - 819
  • [47] High-dose chemotherapy in refractory or relapsed germ cell tumors - Results from sequential trials
    Beyer, J
    Bokemeyer, C
    Rick, O
    Metzner, B
    Casper, J
    Wandt, H
    Hartmann, F
    Schmoll, HJ
    Derigs, G
    Kanz, L
    Huhn, D
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1998, 22 : S43 - S44
  • [48] Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant
    Einhorn, Lawrence H.
    Brames, Mary J.
    Juliar, Beth
    Williams, Stephen D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 513 - 516
  • [49] Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support
    Kollmannsberger, C
    Schleucher, N
    Rick, O
    Metzner, B
    Hartmann, JT
    Schöffski, P
    Beyer, J
    Casper, J
    Sosada, M
    Schmoll, HJ
    Böhlke, I
    Meisner, C
    Kanz, L
    Bokemeyer, C
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (06) : 775 - 782
  • [50] Salvage Chemotherapy With High-Dose Carboplatin and Etoposide With Peripheral Blood Stem Cell Transplant in Patients With Relapsed Pure Seminoma
    Agarwala, Anuj K.
    Perkins, Susan M.
    Abonour, Rafat
    Brames, Mary J.
    Einhorn, Lawrence H.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (03): : 286 - 288
12345